| New insights into therapeutic activity and anticancer properties of curcumin AK Panda, D Chakraborty, I Sarkar, T Khan, G Sa Journal of experimental pharmacology, 31-45, 2017 | 241 | 2017 |
| Curcumin and tumor immune-editing: resurrecting the immune system S Bose, AK Panda, S Mukherjee, G Sa Cell division 10, 1-13, 2015 | 160 | 2015 |
| MEK inhibition prevents tumour‐shed transforming growth factor‐β‐induced T‐regulatory cell augmentation in tumour milieu DMS Hossain, AK Panda, S Chakrabarty, P Bhattacharjee, K Kajal, ... Immunology 144 (4), 561-573, 2015 | 59 | 2015 |
| Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells S Chakraborty, AK Panda, S Bose, D Roy, K Kajal, D Guha, G Sa Scientific reports 7 (1), 1628, 2017 | 48 | 2017 |
| G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53 T Saha, D Guha, A Manna, AK Panda, J Bhat, S Chatterjee, G Sa Scientific reports 6 (1), 32626, 2016 | 30 | 2016 |
| Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis K Kajal, AK Panda, J Bhat, D Chakraborty, S Bose, P Bhattacharjee, ... Scientific Reports 9 (1), 4073, 2019 | 28 | 2019 |
| FOXP3/HAT1 axis controls treg infiltration in the tumor microenvironment by inducing CCR4 expression in breast cancer T Sarkar, S Dhar, D Chakraborty, S Pati, S Bose, AK Panda, U Basak, ... Frontiers in immunology 13, 740588, 2022 | 26 | 2022 |
| Control of memory phenotype T lymphocyte homeostasis: role of costimulation AK Panda, YH Kim, EM Shevach The Journal of Immunology 208 (4), 851-860, 2022 | 12 | 2022 |
| Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients K Kajal, S Bose, AK Panda, D Chakraborty, S Chakraborty, S Pati, ... Cancer Immunology, Immunotherapy, 1-15, 2021 | 10 | 2021 |
| Providence of the CD25+KIR+CD127−FOXP3−CD8+ T‐cell subset determines the dynamics of tumor immune surveillance S Chakraborty, P Bhattacharjee, AK Panda, K Kajal, S Bose, G Sa Immunology and Cell Biology 96 (10), 1035-1048, 2018 | 10 | 2018 |
| Intratumoral immune landscape: immunogenicity to tolerogenicity AK Panda, S Bose, S Chakraborty, K Kajal, G Sa Austin J Clin Immunol 2 (1), 1025, 2015 | 6 | 2015 |
| Cutting edge: Inhibition of the interaction of NK inhibitory receptors with MHC class I augments antiviral and antitumor immunity AK Panda, A Gangaplara, M Buszko, K Natarajan, LF Boyd, S Sharma, ... The Journal of Immunology 205 (3), 567-572, 2020 | 5 | 2020 |
| Cancer-immune therapy: restoration of immune response in cancer by immune cell modulation AK Panda, S Bose, T Sarkar, D Roy, D Chakraborty, S Chakraborty, ... The Nucleus 60, 93-109, 2017 | 4 | 2017 |
| Abstract C106: IMPACT restrains immuno-metabolic GCN1 signaling to govern pancreatic cancer metastasis S Sinha, A Panda, Z Nwosu, RN Das, X Ke, E van Beek, AJ Rossi, ... Cancer Research 84 (2_Supplement), C106-C106, 2024 | | 2024 |
| Global inhibition of Ly-49/MHC-I interactions by anti-MHC-I augments innate and adaptive immunity against cancer metastasis. SM Kazmi, S Sinha, K Natarajan, S Sharma, YH Kim, L Boyd, ... The Journal of Immunology 210 (1_Supplement), 245.08-245.08, 2023 | | 2023 |
| Inhibition of Ly-49/LILRB-MHC-I interactions by anti-MHC-I augments innate and adaptive immunity. AK Panda, K Natarajan, S Sinha, LF Boyd, J Jiang, ME Teke, ... The Journal of Immunology 210 (1_Supplement), 169.14-169.14, 2023 | | 2023 |
| Inhibition of TCR-MHC-II interactions abrogates Treg-mediated immune suppression and augments anti-tumor immunity. AK Panda, EM Shevach The Journal of Immunology 210 (1_Supplement), 169.15-169.15, 2023 | | 2023 |
| Treg cell depletion in adult mice results in activation of antigen-presenting cells prior to fatal autoimmune disease YH Kim, AK Panda, EM Shevach The Journal of Immunology 210 (1_Supplement), 248.03-248.03, 2023 | | 2023 |
| Augmentation of innate and adaptive immunity by inhibition of interaction of lilrbs with mhc-1 Abir Kumar Panda, Ethan Menahem Shevach, David Harvey Margulies, Kannan ... | | 2023 |
| Global inhibition of the interaction of NK inhibitory receptors with MHC-I augments coordinated innate and adaptive immunity against cancer metastasis. AK Panda, S Sinha, K Natarajan, JM Hernandez, DH Margulies, ... The Journal of Immunology 206 (1 Supplement), 57.11-57.11, 2021 | | 2021 |
